Microscope image showing immature egg surrounded by pink cellular structures in ovarian tissue

Softer Ovaries Double Fertility in Aging Rats

🤯 Mind Blown

Scientists discovered that softening ovaries with a new drug doubled conception rates in aging rats and increased litter sizes fivefold. The breakthrough could one day help women conceive later in life and delay menopause-related health risks.

A groundbreaking fertility discovery starts with something surprisingly simple: making ovaries softer could help women conceive at older ages.

Researchers at Huazhong University of Science and Technology in China found that ovaries naturally stiffen as women age, potentially blocking egg development. They identified a protein called interleukin-11 as the culprit, which increases over time and triggers collagen production in the ovaries.

The team tested an experimental drug that blocks this protein in aging rats equivalent to humans in their late 30s or early 40s. The results were remarkable: ovaries became 36 percent less stiff after just four weeks of treatment.

Even more promising, the conception rate doubled from 25 percent to 50 percent in mice. Rat litters grew from an average of one pup to five pups, a fivefold increase that stunned researchers.

The drug worked by silencing the gene responsible for interleukin-11 production. When scientists genetically modified mice to naturally resist this protein, those animals maintained softer ovaries and ovulated more as they aged compared to unmodified mice.

Softer Ovaries Double Fertility in Aging Rats

Why This Inspires

This research arrives at a crucial time. In countries like England and Wales, more women are choosing to have children later in life, often facing declining fertility in their mid-thirties.

Beyond baby-making, the discovery could transform women's health more broadly. Barbara Vanderhyden from the University of Ottawa notes that prolonging ovarian function might delay menopause-related conditions like osteoporosis and heart disease.

The treatment still faces hurdles before human trials. Scientists want to deliver the drug directly to ovaries rather than systemically, since interleukin-11 exists throughout the body. Francesca Duncan at Northwestern University emphasizes that safety standards for ovarian drugs must be exceptionally high since eggs can create the next generation.

The mice and rats showed no known side effects, offering early hope. Researchers also need to determine how long women would need treatment to see benefits.

While years away from pharmacy shelves, this research rewrites what scientists thought possible about extending fertility windows naturally.

More Images

Softer Ovaries Double Fertility in Aging Rats - Image 2
Softer Ovaries Double Fertility in Aging Rats - Image 3
Softer Ovaries Double Fertility in Aging Rats - Image 4
Softer Ovaries Double Fertility in Aging Rats - Image 5

Based on reporting by New Scientist

This story was written by BrightWire based on verified news reports.

Spread the positivity!

Share this good news with someone who needs it

More Good News